Maximus stock overview
Maximus (MMS) has drawn investor attention after a period of weaker share performance, with the stock showing negative returns over the past month and past 3 months. This has prompted closer scrutiny of its current valuation and fundamentals.
See our latest analysis for Maximus.
At a share price of $63.72, Maximus has seen a 30 day share price return of 18.32% and a 90 day share price return decline of 28.50%, while the 1 year total shareholder return sits at a decline of 3.87%. This indicates that momentum has been fading over both shorter and longer periods as investors reassess growth prospects and risk.
If you are weighing Maximus against other opportunities in the services and technology space, it can help to see how companies with automation at their core are trading right now, including 34 robotics and automation stocks
So with Maximus trading at $63.72, sitting at a discount to a US$110 analyst price target and implying an intrinsic discount of around 60%, is this a genuine value opportunity, or is the market already pricing in future growth?
Most Popular Narrative: 42.1% Undervalued
At a last close of $63.72 versus a most widely followed fair value of $110, the current price sits well below what this narrative implies.
The company's ongoing investments in digital, workflow automation, and AI (notably for complex health and claims processing), along with recent inorganic growth and expanded pipeline in federal and state markets, are laying the groundwork for sustainable earnings growth above the rate of revenue growth, as evidenced by recent margin performance and forward guidance.
Want to see what kind of revenue path, margin profile, and future earnings multiple have to come together to back a $110 fair value? The underlying narrative leans on a specific mix of contract wins, profitability assumptions, and capital returns that are all quantified but not obvious from the headline number alone. The details reveal where expectations are most sensitive.
Result: Fair Value of $110 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, this relies on governments continuing to outsource at current levels and on Maximus keeping its technology ahead of in house solutions and larger consulting competitors.
Find out about the key risks to this Maximus narrative.
Next Steps
With sentiment clearly split between concern and optimism, this is a moment to look at the numbers yourself and move quickly to shape your own view. You can start with 5 key rewards and 1 important warning sign
Looking for more investment ideas?
If Maximus is on your radar, do not stop there. A broader watchlist built from different types of opportunities can give you more options when markets shift.
- Target potential mispricings by scanning for companies that combine quality fundamentals with attractive valuations through the 62 high quality undervalued stocks.
- Lock in potential income ideas by reviewing higher yielding companies that appear more resilient using the 13 dividend fortresses.
- Focus on stability first by checking companies that score well on financial strength through the solid balance sheet and fundamentals stocks screener (40 results).
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com